SAB Biotherapeutics

SABS

Market cap $189M

Buy

Hold

Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

Avg. target

$11.33

185% upside

High target

positive

0 neutral

negative

Analyst & Firm	Rating	Price Target	Upside Downside	Date
UBS Michael Yee 100% 1-yr SABS win rate				7 Jan ‘26 12 days ago
Guggenheim Yatin Suneja 100% 1-yr SABS win rate				19 Dec ‘25 1 month ago
Chardan Capital Keay Nakae 86% 1-yr SABS win rate				18 Dec ‘25 1 month ago